Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
ValiScreen Human Melanocortin MC4 Cell Line, CHO-K1 Cells
Stable, recombinant ValiScreen® cell line expressing the Melanocortin MC4 receptor, human recombinant in CHO-K1 host cells.
Product information
Overview
Revvity's ValiScreen® cell lines are provided in two vials of frozen cells, each containing ~2.5 x 106 cells. Detailed product information as well as recommended cell culture conditions and validation assay date are available each cell line.
Clonal selection Revvity's ValiScreen cell lines is carried out with receptor binding. High and low expressors are n tested and selected optimal binding and functional response according to receptor specific transduction pathway.
Revvity's ValiScreen cell lines require accepted cell line Terms and Conditions prior to order processing. Additional agreement needed commercial use. Contact us using Request More Information button above additional information regarding required documentation.
Specifications
| Application |
cAMP
Drug Discovery & Development
|
|---|---|
| Assay Validation |
Binding
cAMP
|
| Assay Target Class |
GPCR
|
| Assay Target Type |
Cell line
|
| Brand |
ValiScreen
|
| G-Alpha Natural Receptor |
Gs
|
| Host |
CHO-K1
|
| Receptor Type |
Melanocortin
|
| Second Messenger Release |
cAMP
|
| Species |
Human
|
| Shipping Conditions |
Shipped in Dry Ice
|
| Special Ordering Information |
Requires accepted Terms and Conditions. Additional agreement needed for commercial use.
|
| Therapeutic Area |
Central Nervous System
Inflammation
Metabolic
Pain
|
| Unit Size |
5 million cells
|
Resources
GPCR activity for the subunits Gαs and Gαi is commonly assessed by measuring levels of intracellular cAMP upon stimulation by...
Discover a comprehensive collection of GPCR cell lines, membrane preparations, and complementary radioligands designed to drive...
Related products
How can we help you?
We are here to answer your questions.
